ID Name Structure References (top 5) Molecular Target(s)
1ID:969
CEPHALOTAXINE


NSC#:128487
NSC#:239389
NSC#:245454
NSC#:245455
Aldrich#:C6530

Freqency:
in 5 ingredients:

  • 9
  • 51
  • 368
  • 429
  • 459

  • Properties
    C18H21NO4    315.37





    1:  Grem JL, Cheson BD, King SA, Leyland-Jones B, Suffness M.
    Cephalotaxine esters: antileukemic advance or therapeutic failure?
    J Natl Cancer Inst.    impact factor:   12.945
    1988;  80(14): 1095-103

    2:  Zhou JY, Chen DL, Shen ZS, Koeffler HP.
    Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro.
    Cancer Res.    impact factor:   8.614
    1990;  50(7): 2031-5

    3:  Neidhart JA, Young DC, Kraut E, Howinstein B, Metz EN.
    Phase I trial of homoharringtonine administered by prolonged continuous infusion.
    Cancer Res.    impact factor:   8.614
    1986;  46(2): 967-9

    4:  Suga S, Watanabe M, Yoshida J.
    Electroauxiliary-Assisted Sequential Introduction of Two Carbon Nucleophiles on the Same alpha-Carbon of Nitrogen: Application to the Synthesis of Spiro Compounds.
    J Am Chem Soc.    impact factor:   5.537
    2002;  124(50): 14824-5

    5:  Schwab JM, Chang MN, Parry RJ.
    Biosynthesis of Cephalotaxus alkaloids. 3. Specific incorporation of phenylalanine into cephalotaxine.
    J Am Chem Soc.    impact factor:   5.537
    1977;  99(7): 2368-78

     
    Time used: 94 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005